Central action of melanostatin (MIF-1) in mice. 1984

R Brus, and R Szkilnik, and B Stanosek, and B Makowska, and J Piguła

The effects of MIF-1 administered into a lateral ventricle of the brain were studied on the behaviour of mice in the open field test and hole test, apomorphine-induced stereotypy, morphine-induced catalepsy, and reactivity on thermal painful stimuli in the hot plate test. The last test was compared with a similar test with morphine administration. It was demonstrated that MIF-1 exerted a depressing effect on the behaviour of mice, increased the intensity of apomorphine-induced stereotypy and weakened chlorpromazine-induced catalepsy. Moreover, an analgesic action of MIF-1 was demonstrated which was blocked with naloxone. The results of these investigations indicated a significant central action of MIF-1 in mice and a participation of dopaminergic receptors in certain effects of MIF-1 on the behaviour of experimental animals.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009075 MSH Release-Inhibiting Hormone A hypothalamic tripeptide, enzymatic degradation product of OXYTOCIN, that inhibits the release of MELANOCYTE-STIMULATING HORMONES. MSH Release-Inhibiting Factor,Melanocyte-Stimulating Hormone Release-Inhibiting Hormone,Prolyl-Leucyl-Glycinamide,H-Pro-Leu-Gly-NH2,MIF-1,MIF-I,Melanocyte-Stimulating Hormone Release-Inhibiting Factor,Melanostatin,Oxytocin (7-9),Pro-Leu-Gly-NH2,Pro-Leu-Glyamide,Prol-Leu-Gly-NH2,Prolylleucylglycinamide,Prol Leu Gly NH2,Prolyl Leucyl Glycinamide
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D002375 Catalepsy A condition characterized by inactivity, decreased responsiveness to stimuli, and a tendency to maintain an immobile posture. The limbs tend to remain in whatever position they are placed (waxy flexibility). Catalepsy may be associated with PSYCHOTIC DISORDERS (e.g., SCHIZOPHRENIA, CATATONIC), nervous system drug toxicity, and other conditions. Cerea Flexibilitas,Flexibility, Waxy,Anochlesia,Anochlesias,Catalepsies,Flexibilitas, Cerea,Flexibilities, Waxy,Waxy Flexibilities,Waxy Flexibility
D002552 Cerebral Ventricles Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE). Foramen of Monro,Cerebral Ventricular System,Cerebral Ventricle,Cerebral Ventricular Systems,Monro Foramen,System, Cerebral Ventricular,Systems, Cerebral Ventricular,Ventricle, Cerebral,Ventricles, Cerebral,Ventricular System, Cerebral,Ventricular Systems, Cerebral
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R Brus, and R Szkilnik, and B Stanosek, and B Makowska, and J Piguła
June 1983, Polski tygodnik lekarski (Warsaw, Poland : 1960),
R Brus, and R Szkilnik, and B Stanosek, and B Makowska, and J Piguła
January 1979, Acta pharmaceutica Suecica,
R Brus, and R Szkilnik, and B Stanosek, and B Makowska, and J Piguła
August 1985, Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova,
R Brus, and R Szkilnik, and B Stanosek, and B Makowska, and J Piguła
January 1980, Acta pharmaceutica Suecica,
R Brus, and R Szkilnik, and B Stanosek, and B Makowska, and J Piguła
January 1983, Nauchnye doklady vysshei shkoly. Biologicheskie nauki,
R Brus, and R Szkilnik, and B Stanosek, and B Makowska, and J Piguła
January 1997, Polish journal of pharmacology,
R Brus, and R Szkilnik, and B Stanosek, and B Makowska, and J Piguła
April 1988, European journal of pharmacology,
R Brus, and R Szkilnik, and B Stanosek, and B Makowska, and J Piguła
January 1986, Peptides,
R Brus, and R Szkilnik, and B Stanosek, and B Makowska, and J Piguła
April 2007, Autonomic & autacoid pharmacology,
R Brus, and R Szkilnik, and B Stanosek, and B Makowska, and J Piguła
May 1990, The International journal of neuroscience,
Copied contents to your clipboard!